My Department and the HSE work continuously to monitor and improve patient safety, reduce incidents of harm and to minimise risk.
Government recently approved the establishment of an Interdepartmental Working Group to examine the rising cost of health-related claims and consider mechanisms to reduce costs. The Group will examine the rising cost of clinical negligence claims in the health system, with a particular focus on high value claims, and identify measures that could be put in place to reduce future costs. The Group is chaired independently by an expert healthcare professional, Dr Rhona Mahony, and is comprised of membership from across key Government Departments and Agencies.
With respect to vaccination, patients concerned with a possible side-effect or adverse reaction following a vaccination should, in the first instance, consult with their medical practitioner who can refer them as necessary to appropriate services following clinical assessment.
It should also be noted that vaccines can only be approved and used if they comply with all the requirements of quality, safety and efficacy set out in relevant EU pharmaceutical legislation. Any authorised vaccine will be subject to ongoing monitoring in Ireland by the Health Products Regulatory Authority (HPRA). The latest safety updates from the HPRA regarding COVID-19 vaccinations are available on the HPRA’s website.
Regarding a vaccine damage compensation scheme, during the pandemic, all available Department of Health resources were devoted to the Public Health response. This has meant that work in this area could not be progressed. Further scoping work is required to inform decision-making in this area. This remains under consideration by my Department.
